Skip to Main Content

Effective May 22, 2023: Clinical Policies

Date: 05/17/23

Superior HealthPlan has updated certain policies to ensure medical necessity review criteria is current and appropriate for members and the scope of services provided. As a result the following policies are effective on May 22, 2023, at 12:00AM.

Changes in these policies reflect preauthorization requirement amendments that are less burdensome to insureds, physicians, or health care providers.

POLICY

APPLICABLE PRODUCTS

NEW POLICY OVERVIEW OR UPDATED POLICY REVISIONS

Skin Substitutes for Chronic Wounds

(CP.MP.185)

Ambetter

Policy updates include:

  • Changed policy title and statements in I. and II. to reflect the inclusion of soft tissue substitutes for chronic wounds
  • Added note specifying that requests for skin and soft tissue substitutes other than for the indications noted in the policy is outside of the scope of the policy
  • Updated policy statement I. to include full thickness skin-loss ulcers
  • Revised criteria I.G. In I.H clarified that the request complies with FDA-approved indications and application limits
  • Removed criteria II.A. Reworded extraneous language and background updated with no clinical significance. Removed deleted HCPCS code A2003
  • Labeled HCPCS Table 1 to note support of medical necessity
  • Added HCPCS Table 2 of codes that do not support medical necessity
  • Moved the following codes from the previous code reference table to table 2, HCPCS codes that do not support medical necessity: A2002, A2005, A2006, A2007, A2009, A2010, Q4184, Q4199, Q4237, Q4238, Q4239, Q4262, Q4263, and Q4264 Added new codes Q4253, Q4262, Q4263 and Q4264 to HCPCS table 1
  • Added additional codes to not medically necessary table, Table 2

Therapeutic Utilization of Inhaled Nitric Oxide

(CP.MP.87)

Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP, and Ambetter

Policy updates include:

  • Policy title updated from “Inhaled Nitric Oxide” to “Therapeutic Utilization of Inhaled Nitric Oxide”
  • Minor rewording in Description, criteria I.B.1., I.B.1.a., I.B.1.b., and I.B.1.c
  • Added recommended iNO dose in criteria I.B.1.e
  • Minor rewording in criteria I.B.2.b
  • Minor rewording in criteria II., II.B.1.a., II.B.1.c., and II.B.1.d
  • Removed response requirement of “within two hours” in criteria II.B.1.e. and added recommended iNO dose in criteria II.B.1.e
  • Minor rewording in criteria II.B.2.b. and in criteria III
  • Added clarifying language to criteria III.A.1. and minor rewording to criteria III.A.2
  • Updated notation in criteria III. from 48 hours to 72 hours
  • Minor rewording in criteria IV. and in criteria Treatment Regimen section
  • Removed ICD-10 codes

 

Wheelchair Seating

(CP.MP.99)

Ambetter

Policy updates include:

  • Added "dementia" and "hereditary motor and sensory neuropathy" to I.B.2
  • Added "congenital absence of thigh and/or lower limb" to I.C.2
  • Added ICD-10 codes F03.90, F03.911, F03.918, F03.92, F03.93, F03.94, F03.A11, F03.A18, F03.A2, F03.A3, F03.A4, F03.B11, F03.B18, F03.B2, F03.B3, F03.B4, F03.C11, F03.C18, F03.C2, F03.C3, F03.C4, G31.83, G60.0, Q79.60, Q79.61, Q79.62, Q79.63, Q79.69, Q90.0, Q90.1, Q90.2, Q90.9, G71.031, G71.032, G71.033, G71.0340, G71.0341, G71.0342, G71.0349, G71.035, G71.038, and G71.039 to tables with the following HCPCS codes: E2603, E2604, E2622, and E2623; E0953, E0956, E0957, E0960, E2605, E2606, E2613, E2614, E2615, E2616, E2617, E2620, and E2621; E2607, E2608, E2624, and E2625; and E2609
  • Added Q72.01, Q72.02, Q72.03, Q72.11, Q72.12, and Q72.13 to tables with the following HCPCS codes: E2607, E2608, E2624, and E2625; and E0953, E0956, E0957, E0960, E2605, E2606, E2613, E2614, E2615, E2616, E2617, E2620, and E2621; and E2609

To review all policies, please visit Superior’s Clinical, Payment & Pharmacy Policies webpage.

Prior to updates, Medical Clinical policies are reviewed and approved by the Utilization Management Committee.

For questions or additional information, contact Superior HealthPlan Prior Authorization department at 1-800-218-7508.